Early-Stage drug safety trial in healthy volunteers halted
NCT ID NCT06716190
First seen Mar 27, 2026
Summary
This early-stage trial aimed to check the safety and how the body handles a new drug called BI 3731579. It involved 30 healthy adults who took multiple doses over 15 days. The study was terminated early, and no results are available. Since it only tested safety in healthy people, there was no direct treatment benefit.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
SGS Life Science Services - Clinical Research
Edegem, 2650, Belgium
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.